Mycophenolic acid (INN) (IPA: ) or mycophenolate is an immunosuppresant drug used to prevent rejection in organ transplantation. It was initially marketed as the prodrug mycophenolate mofetil (abbreviated MMF) to improve oral bioavailability. More recently, the salt mycophenolate sodium has also been introduced. Mycophenolic acid is commonly marketed under the trade names Cellcept (mycophenolate mofetil; Roche) and Myfortic (mycophenolate sodium; Novartis).
Mycophenolate is therefore a potent anti-proliferative, and can be used in place of the older anti-proliferative azathioprine. It is usually used as part of triple therapy including a calcineurin inhibitor (ciclosporin or tacrolimus) and prednisolone.
More on [ Mycophenolic acid ]

Mycophenolate Mofetil - Information for patients in English and Spanish.